Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Non Operating Income: 2019-2024

Historic Non Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $1.2 million.

  • Mirum Pharmaceuticals' Non Operating Income rose 136.34% to $395,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 235.64%. This contributed to the annual value of $1.2 million for FY2024, which is 142.95% up from last year.
  • Mirum Pharmaceuticals' Non Operating Income amounted to $1.2 million in FY2024, which was up 142.95% from -$2.8 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Non Operating Income registered a high of $1.2 million during FY2024, and its lowest value of -$2.8 million during FY2023.
  • Over the past 3 years, Mirum Pharmaceuticals' median Non Operating Income value was $365,000 (recorded in 2022), while the average stood at -$415,333.
  • In the last 5 years, Mirum Pharmaceuticals' Non Operating Income soared by 162.71% in 2022 and then slumped by 873.70% in 2023.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Non Operating Income stood at -$192,000 in 2020, then slumped by 203.12% to -$582,000 in 2021, then soared by 162.71% to $365,000 in 2022, then slumped by 873.70% to -$2.8 million in 2023, then skyrocketed by 142.95% to $1.2 million in 2024.